Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
480
datasets available to search
ShareScore release 0.7.1
Dataset results
480 results for “Hormone Receptors”
Pre-operative Hormonal Treatment for Hormone Receptor Positive Breast Cancer
ClinicalTrials.gov study NCT00738777. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Capecitabine or Endocrinotherapy as a Maintenance Therapy Regimen at Least 2nd Line in Hormone Receptor Positive and HER2 Negative Metastatic Breast Cancer
ClinicalTrials.gov study NCT03204734. IPD Sharing: NO. Countries: 1. Publications: 1.
PAlbociclib Plus Tamoxifen for the Treatment of Hormone Receptor-positive, HER2-negative Advanced Breast Cancer Women - Asian studY
ClinicalTrials.gov study NCT03423199. IPD Sharing: Not stated. Countries: 4. Publications: 1.
The Evaluation of the Efficacy and Tolerability of FASLODEX (Fulvestrant) and AROMASIN (Exemestane) in Hormone Receptor Positive Postmenopausal Women With Advanced Breast Cancer
ClinicalTrials.gov study NCT00065325. IPD Sharing: Not stated. Countries: 15. Publications: 1.
Hormone Therapy in Treating Postmenopausal Women With Receptor-Positive Breast Cancer
ClinicalTrials.gov study NCT00002646. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Anlotinib-based Combination Therapy in Patients with Hormone Receptor-positive（HR+） Metastatic Breast Cancer(MBC) .
ClinicalTrials.gov study NCT06734533. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Usefulness of Ki67 Index in Hormone Receptor-positive Breast Cancer
ClinicalTrials.gov study NCT01273415. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Comparison of Blood Levels of Two Formulations of the Selective Hormone Receptor Modulator CDB-2914
ClinicalTrials.gov study NCT00041899. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Endocrine Therapy Plus CDK4/6 in First or Second Line for Hormone (SONIA) Receptor Positive Advanced Breast Cancer
ClinicalTrials.gov study NCT03425838. IPD Sharing: NO. Countries: 1. Publications: 4.
ABCSG 8 - Adjuvant Treatment in Patients With Hormone Receptor-positive Breast Cancer With Good to Moderate Differentiation.
ClinicalTrials.gov study NCT00291759. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Defined Green Tea Catechin Extract in Treating Women With Hormone Receptor Negative Stage I-III Breast Cancer
ClinicalTrials.gov study NCT00516243. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Anastrozole Biphosphonate Study in Postmenopausal Women With Hormone-Receptor-Positive Early Breast Cancer
ClinicalTrials.gov study NCT00082277. IPD Sharing: Not stated. Countries: 8. Publications: 1.
Disitamab Vedotin (RC48) in Hormone Receptor Positive, HER2-low Metastatic Breast Cancer (the Rosy Trial)
ClinicalTrials.gov study NCT05904964. IPD Sharing: NO. Countries: 1. Publications: 9.
Anastrozole Reduced Proliferation and Progesterone Receptor Indexes in Short Term Hormone Therapy
ClinicalTrials.gov study NCT01016665. IPD Sharing: Not stated. Countries: 1. Publications: 16.
Pembrolizumab And Tamoxifen Among Women With Advanced Hormone Receptor Positive Breast Cancer And Esr1 Mutation
ClinicalTrials.gov study NCT03879174. IPD Sharing: NO. Countries: 1. Publications: 4.
Capecitabine in Combination With Aromatase Inhibitor Versus Aromatase Inhibitors, in Hormonal Receptor Positive Recurrent or Metastatic Breast Cancer Patients, Randomized Controlled Study
ClinicalTrials.gov study NCT04012918. IPD Sharing: Not stated. Countries: 1. Publications: 12.
Onapristone as Preoperative Treatment for Postmenopausal Women With Hormone Receptor + and HER2- Breast Cancer
ClinicalTrials.gov study NCT04142892. IPD Sharing: NO. Countries: 1. Publications: 0.
Metronomic Treatment With Daily Oral Vinorelbine as First-line Chemotherapy in Patients With Advanced/Metastatic Hormone Receptor Positive (HR+)/Human Epidermal Growth Factor Receptor 2 Negative (HER2
ClinicalTrials.gov study NCT03007992. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Pregnane X Receptor (PXR) Agonist Rifampicin Effects on Glucose, Lipid and Hormone Homeostasis
ClinicalTrials.gov study NCT00985270. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Fasting Mimicking Diet Program to ImpRovE ChemoTherapy in Hormone Receptor Postive (HR+), HER2- Breast Cancer
ClinicalTrials.gov study NCT05503108. IPD Sharing: NO. Countries: 1. Publications: 4.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.